CMS advised BioNTech SE (Nasdaq: BNTX) on the deal. BioNTech SE (Nasdaq: BNTX), a German biotechnology company, acquired a GMP-certified manufacturing facility in Singapore from Novartis...
This content is for Standard 1 Year members only. LoginJoin Now